Berlin, Germany
ProBioGen AG, operating under the slogan Intelligent Biopharmaceutical Solutions, is a key player in the biopharmaceutical sector. As a contract development and manufacturing organization (CDMO) and technology provider, it excels in cell line development, process development, and GMP manufacturing, focusing on proteins, antibodies, viral vectors, and vaccines. The company distinguishes itself with proprietary technologies augmenting biopharmaceutical manufacturing and analysis.
Founded in 1994 as a spin-off from the Charité, ProBioGen AG leverages over 30 years of experience, maintaining three manufacturing facilities in Berlin. The company employs a workforce of 300, dedicated to pioneering next-generation therapies and fostering global biotech advancements. Despite its robust history and operation scale, details concerning any recent investment or headquarter information remain undisclosed, which may be an area of interest for potential investors.
